10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-012515`
Period End Date	20151231
Filing Date	20160209
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	arwr-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 37 Cash Flow Statement 49 Stockholders Equity 11

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$62.17M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.99M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.78M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.29M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$823.62K	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$14.43M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$17.54M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$82.28M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$102.87M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	59.54M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	59.63M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.67M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	59.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	59.54M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.53M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.39M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.82M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$45.79K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$45.79K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$111.38M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$132.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.03M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.29M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.38M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.92M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.82M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.42M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$109.38K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.30M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.33M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$217.55K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$218.45K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$12.33M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$15.90M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$485.84K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$540.79K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.86M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.86M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$336.43K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$342.45K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$6.75M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$6.68M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 shares issued and outstanding as of December 31, 2015 and September 30, 2015	`PreferredStockValue`	$16.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 shares issued and outstanding as of December 31, 2015 and September 30, 2015	`PreferredStockValue`	$16.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 59,627,499 and 59,544,677 shares issued and outstanding as of December 31, 2015 and September 30, 2015, respectively	`CommonStockValue`	$151.91K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 59,627,499 and 59,544,677 shares issued and outstanding as of December 31, 2015 and September 30, 2015, respectively	`CommonStockValue`	$152.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.87M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$428.84M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-90.61K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-136.43K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-316.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-335.98M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$92.92M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$110.18M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.37M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$111.38M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$132.27M	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$170.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$17.74M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$10.34M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.15M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.92M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.95M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.09M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.01M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.38M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$794.35K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$290.04K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$19.39M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$25.29M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-19.34M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-25.12M	USD	1 Quarter
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-26.38K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$237.42K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$100.38K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.38M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-23.52K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-53.18K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.54M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$76.86K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.26M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.58M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-22.58M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-19.26M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.58M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.69M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.55M	shares	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$45.82K	USD	1 Quarter
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-19.22M	USD	1 Quarter
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-22.58M	USD	1 Quarter

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-22.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-19.26M	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-26.38K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.38M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-23.52K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.38M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.01M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$794.35K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$290.04K	USD	1 Quarter
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$108.40K	USD	1 Quarter
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$347.70K	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$1.05M	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$136.51K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.87M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$490.06K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$257.22K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.42M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.95M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.33M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$42.79K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-802.00	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-24.20M	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-21.15M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$406.61K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$554.95K	USD	1 Quarter
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$500.00	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.00M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.05M	USD	1 Quarter
Cash paid for acquisitions	`PaymentsToAcquireAssetsInvestingActivities`	$7.00M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-4.50M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$2.59M	USD	1 Quarter
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$103.17K	USD	1 Quarter
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$54.05K	USD	1 Quarter
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$440.53K	USD	1 Quarter
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$283.47K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$180.30K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-494.58K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-19.05M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-28.52M	USD	1 Quarter
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$62.17M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$103.99M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$62.17M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$103.99M	USD	Point-in-time
Interest paid	`InterestPaid`	$3.05K	USD	1 Quarter
Interest paid	`InterestPaid`	$3.94K	USD	1 Quarter

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.37M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$25.54K	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	4,687.00	shares	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.38M	USD	1 Quarter
Common stock-RSU vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-440.53K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$45.82K	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-19.26M	USD	1 Quarter
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.37M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.